top of page

Publications

Original Article

A degenerate HLA-DR epitope pool of HER-2/neu reveals a novel in vivo immunodominant epitope, HER-2/neu88-102

Cancer Vaccines

2010

Authors:

Karyampudi, L., Formicola, C., Erskine, C. L., Maurer, M. J., Ingle, J. N., Krco, C. J., Wettstein, P. J., Kalli, K. R., Fikes, J. D., Beebe, M., Hartmann, L. C., Disis, M. L., Ferrone, S., Ishioka, G., Knutson, K. L.

Journal:

Clinical Cancer Research

Volume:

16(3)

Page:

825-34

Review Article

Enhancing cancer vaccine efficacy via modulation of the tumor microenvironment

Tumor Microenvironment

2009

Authors:

Disis, M.L.

Journal:

Clinical Cancer Research

Volume:

15(21)

Page:

6476-8

Review Article

FOXP3 expression and prognosis: role of both the tumor and T cells

Tumor Microenvironment

2009

Authors:

Lu, H.

Journal:

Journal of Clinical Oncology

Volume:

27(11)

Page:

1735-6

Review Article

Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology

2009

Authors:

Tahara H., Sato M., Thurin M., Wang E., Butterfield L.H., Disis M.L., Fox B.A., Lee P.P., Khleif S.N., Wigginton J.M., Ambs S., Akutsu Y., Chaussabel D., Doki Y., Eremin O., Fridman W.H., Hirohashi Y., Imai K., Jacobson J., Jinushi M., Kanamoto A., Kashani-Sabet M., Kato K., Kawakami Y., Kirkwood J.M., Kleen T.O., Lehmann P.V., Liotta L., Lotze M.T., Maio M., Malyguine A., Masucci G., Matsubara H., Mayrand-Chung S., Nakamura K., Nishikawa H., Palucka A.K., Petricoin E.F., Pos Z., Ribas A., Rivoltini L., Sato N., Shiku H., Slingluff C.L., Streicher H., Stroncek D.F., Takeuchi H., Toyota M., Wada H., Wu X., Wulfkuhle J., Yaguchi T., Zeskind B., Zhao Y., Zocca M.B., Marincola F.M.

Journal:

Journal of Translational Medicine

Volume:

7

Page:

45

Review Article

Use of tumour-responsive T cells as cancer treatment

T Cell Function & Therapy

2009

Authors:

Disis M.L., Bernhard H., Jaffee E.M.

Journal:

Lancet

Volume:

373(9664)

Page:

673-83

Original Article

Toward a stem cell gene therapy for breast cancer

General Immune Research

2009

Authors:

Li Z, Liu Y, Tuve S, Xun Y, Fan X, Min L, Feng Q, Kiviat N, Kiem HP, Disis ML, Lieber A.

Journal:

Blood

Volume:

113(22)

Page:

5423-5433

Review Article

Immunomodulation of breast cancer via tumor antigen specific Th1

Cancer Vaccines

2009

Authors:

Disis M.L., Park K.H.

Journal:

Cancer Research Treatment

Volume:

41(3)

Page:

117-21

Review Article

Cellular Immune Strategies For Cancer Therapy

T Cell Function & Therapy

2009

Authors:

Disis ML, Jaffe EM and Bernhard H

Journal:

Lancet

Volume:

Page:

Pubmed:

Original Article

Concurrent trastuzumab and HER2/neu-specific vaccination in patients with metastatic breast cancer

Cancer Vaccines

2009

Authors:

Disis ML, Wallace DR, Gooley TA, Dang Y, Slota M, Lu H, Coveler AL, Childs JS, Higgins DM, Fintak PA, Dela Rosa C, Tietje K, Link J, Waisman J, Salazar LG.

Journal:

Journal of Clinical Oncology

Volume:

27(28)

Page:

4685-92

Original Article

In situ adenovirus vaccination engages T effector cells against cancer

Cancer Vaccines

2009

Authors:

Tuve S, Liu Y, Tragoolpua K, Jacobs JD, Yumul RC, Li ZY, Strauss R, Hellstrom KE, Disis ML, Roffler S, Lieber A.

Journal:

Vaccine

Volume:

27(31)

Page:

4225-39

bottom of page